Page last updated: 2024-11-05

tranexamic acid and Diabetic Retinopathy

tranexamic acid has been researched along with Diabetic Retinopathy in 2 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Research Excerpts

ExcerptRelevanceReference
"Thirty one diabetic patients were prospectively randomized for treatment with or without tranexamic acid during vitrectomy for proliferative diabetic retinopathy."5.06Effect of tranexamic acid on postvitrectomy haemorrhage in diabetic patients. ( Immonen, I; Laatikainen, L; Summanen, P, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ramezani, AR1
Ahmadieh, H1
Ghaseminejad, AK1
Yazdani, S1
Golestan, B1
Laatikainen, L1
Summanen, P1
Immonen, I1

Trials

2 trials available for tranexamic acid and Diabetic Retinopathy

ArticleYear
Effect of tranexamic acid on early postvitrectomy diabetic haemorrhage; a randomised clinical trial.
    The British journal of ophthalmology, 2005, Volume: 89, Issue:8

    Topics: Adult; Aged; Antifibrinolytic Agents; Confounding Factors, Epidemiologic; Diabetic Retinopathy; Drug

2005
Effect of tranexamic acid on postvitrectomy haemorrhage in diabetic patients.
    International ophthalmology, 1987, Volume: 10, Issue:3

    Topics: Adolescent; Adult; Aged; Cyclohexanecarboxylic Acids; Diabetes Complications; Diabetic Retinopathy;

1987